Company Overview
Company Name
Albany Ketamine Infusions
Address
7 Wembley Ct, Albany, NY, 12205, United States
Website
albanyketamine.comPhone
(518) 249-5700Approx. Annual Revenue
$3.0M
About Albany Ketamine Infusions
Albany Ketamine Infusions is a leading provider of ketamine infusion therapy in Albany, New York. The company specializes in the treatment of depression, PTSD, anxiety, and chronic pain, offering patients relief through innovative and effective intravenous ketamine treatments.
Frequently Asked Questions about Albany Ketamine Infusions
Advertising Pixels
- Facebook Ad Pixel
Technologies Used
'%3e%3ccircle%20id='Ellipse_1'%20data-name='Ellipse%201'%20cx='434.5'%20cy='434.5'%20r='434.5'%20transform='translate(493%2061)'%20fill='%2307223d'/%3e%3cg%20id='Group_1'%20data-name='Group%201'%20transform='translate(617.184%20224.258)'%3e%3crect%20id='Rectangle_1'%20data-name='Rectangle%201'%20width='80.606'%20height='430.93'%20transform='translate(91.97%20109.538)'%20fill='%23fdc400'/%3e%3cpath%20id='Path_1'%20data-name='Path%201'%20d='M18.4,26.659l80.606,76.473V26.659Z'%20transform='translate(73.569%20106.573)'%20fill='%2392792d'/%3e%3cpath%20id='Path_2'%20data-name='Path%202'%20d='M132.276,0,0,138.472H264.9Z'%20transform='translate(0%200)'%20fill='%23fdc400'/%3e%3crect%20id='Rectangle_2'%20data-name='Rectangle%202'%20width='92.32'%20height='236.28'%20transform='translate(263.686%20304.188)'%20fill='%232896fb'/%3e%3cpath%20id='Path_3'%20data-name='Path%203'%20d='M51.936,65.609l96.453,83.334V65.609Z'%20transform='translate(207.619%20262.276)'%20fill='%231b6198'/%3e%3cpath%20id='Path_4'%20data-name='Path%204'%20d='M36.02,177.426,168.3,38.949l132.62,138.478Z'%20transform='translate(143.992%20155.702)'%20fill='%232896fb'/%3e%3crect%20id='Rectangle_3'%20data-name='Rectangle%203'%20width='80.606'%20height='430.925'%20transform='translate(447.656%20109.608)'%20fill='%234acf27'/%3e%3cpath%20id='Path_5'%20data-name='Path%205'%20d='M89.575,26.672l80.606,76.473V26.672Z'%20transform='translate(358.083%20106.625)'%20fill='%23327f3e'/%3e%3cpath%20id='Path_6'%20data-name='Path%206'%20d='M71.172,138.49h264.9L203.448.012Z'%20transform='translate(284.514%200.051)'%20fill='%234acf27'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
;%20fill-rule:%20evenodd;%20}%20.cls-2%20{%20fill:%20none;%20}%20%3c/style%3e%3clinearGradient%20id='linear-gradient'%20x1='-1275.62'%20y1='432.1'%20x2='-1272.18'%20y2='427.35'%20gradientTransform='translate(30659%2010381.36)%20scale(24%20-24)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0'%20stop-color='%2325c5ff'/%3e%3cstop%20offset='.45'%20stop-color='%230048ff'/%3e%3cstop%20offset='1'%20stop-color='%23c500f3'/%3e%3c/linearGradient%3e%3c/defs%3e%3cpath%20class='cls-2'%20d='M0,0H150V150H0V0Z'/%3e%3cg%20id='Layer_2'%20data-name='Layer%202'%3e%3cg%20id='Layer_1-2'%20data-name='Layer%201-2'%3e%3cg%20id='Artboard'%3e%3cg%20id='userway_logo'%20data-name='userway%20logo'%3e%3cpath%20id='Combined-Shape'%20class='cls-1'%20d='M18.75,36.94c5.16-.03,9.36,4.13,9.39,9.28,0,.03,0,.07,0,.1h0v7.3h0v23.47c0,26.79,21.71,48.5,48.5,48.5s48.5-21.71,48.5-48.5h0v-23.99h0v-7.3c-.03-5.16,4.13-9.36,9.28-9.39,.03,0,.07,0,.1,0h4.69v40.68c0,34.56-28.02,62.58-62.58,62.58S14.06,111.66,14.06,77.1h0V36.94h4.69Zm2.09-22.42c16.1-.03,29.18,13,29.2,29.1,0,.03,0,.07,0,.1v33.38c0,14.69,11.91,26.6,26.6,26.6s26.6-11.91,26.6-26.6V43.72c-.03-16.1,13-29.18,29.1-29.2,.03,0,.07,0,.1,0h6.78v14.08h-6.78c-8.35,0-15.12,6.77-15.12,15.12v33.38c0,22.18-17.98,40.16-40.16,40.16h0c-22.28,.03-40.42-17.88-40.68-40.16V43.72c-.08-8.44-6.99-15.21-15.43-15.13-.07,0-.14,0-.21,0h-6.78V14.52h6.78Z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Key Decision Makers
Philip Hansen Owner
Glen Brooks Owner